Connect With Us
Subscribe Now
Log In
Home
News
Education
Health
Tech
STEM
Advanced Manufacturing & Logistics
Life Sciences
Ag INnovation
INPower
Videos
Big Wigs
Submit Big Wigs
Events
Innovate Southwest Indiana â Evansville
Innovate West Central Indiana – Terre Haute
Innovate East Central – Muncie
Innovate Northeast Indiana – Fort Wayne
Newsletters
Podcasts
On-Air
TV & Radio Listings
Content Studio
Sponsored Content
Contact
About IIB
Meet the Team
Contact Us
Advertise
Gift Cards
Flagship Stations
Gerry’s Message
Speaking Engagement Request
Search
GO
Connect With Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
SPX
Gold
Crude+Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about Biotech
Recent news which mentions Biotech
< Previous
1
2
...
26
27
28
29
30
31
32
33
Next >
Eli Lilly Launches Flat Pricing For Zepbound, Capping Monthly Cost At $499
June 16, 2025
Tickers
LLY
NEWS
Tags
Health Care
News
Briefs
From
Benzinga
Incyte's Experimental Therapy Shows Platelet Normalization And Safety In Rare Blood Cancer Trials Across Doses
June 16, 2025
Tickers
INCY
NEWS
Tags
Movers
Stories That Matter
Analyst Ratings
From
Benzinga
Sarepta Therapeutics Stock Plummets Over 40% On Second Fatal Case Linked To Its Gene Therapy
June 16, 2025
Tickers
NEWS
RHHBY
SRPT
Tags
Briefs
FDA
why it's moving
From
Benzinga
Five things: Red Sox sweep, largest-ever ranking, BIO, Logan 'remote terminals' and where I’ll be today
June 16, 2025
Tags
Roundup
Boston 5 Things Editorial 2015
Biotech
From
Business Journals
Merck's Keytruda Secures FDA Nod For Head And Neck Cancer As First Immunotherapy For Use Around Surgery
June 13, 2025
Tickers
MLTX
MRK
NEWS
Tags
News
Top Stories
MRK
From
Benzinga
FDA Approves UroGen's Zusduri As First Drug For Recurrent Bladder Cancer
June 13, 2025
Tickers
NEWS
URGN
Tags
Market News
Benzinga
Health Care
From
Benzinga
Zepbound Put Eli Lilly On Top — Now Its Next Big Move Could Supercharge The Stock
June 13, 2025
Tickers
LLY
Tags
Stories That Matter
Weight Loss
weight loss drugs
From
Benzinga
Novo Nordisk Moves Amycretin Into Phase 3 Trials For Weight Management, Becomes Europe's Largest Company
June 13, 2025
Tickers
LLY
NEWS
NVO
NVS
Tags
Benzinga
Market News
LLY
From
Benzinga
Medtronic Is Separating Its Diabetes Business - Good News For Investors
June 13, 2025
Tickers
IPOS
MDT
Tags
Long Ideas
Market News
Biotech
From
Benzinga
AstraZeneca Inks Research Pact With China's CSPC Pharmaceuticals Focused On AI-Driven Research, Valued Up To $5.33 Billion
June 13, 2025
Tickers
AZN
NEWS
Tags
Large Cap
General
Benzinga
From
Benzinga
Five things: BIO in Boston, 'Loganing,' Petri Dish, small-business AI and welcome to 'the jungle'
June 13, 2025
Tags
Awards
Human Resources
Career & Workplace
From
Business Journals
Recently Listed Tvardi Therapeutics' Lead Drug 'Positioned To Drive Broad Improvement', Analyst Sees Over 150% Stock Upside
June 12, 2025
Tickers
NEWS
TVRD
Tags
Benzinga
Market News
Expert Ideas
From
Benzinga
Novartis' Fabhalta Delivers Hemoglobin Gains, Reduces Fatigue In Patients With Rare Blood Disorder
June 12, 2025
Tickers
AZN
NEWS
NVS
Tags
Large Cap
General
Biotech
From
Benzinga
Biogen, UCB Take A Leap In Lupus With Promising Phase 3 Results
June 12, 2025
Tickers
BIIB
NEWS
UCBJF
UCBJY
Tags
Market News
Benzinga
General
From
Benzinga
BioNTech Expands mRNA Cancer Portfolio With CureVac $1.25 Billion All-Stock Deal
June 12, 2025
Tickers
BMY
BNTX
CVAC
MRNA
Tags
Movers
Mergers and Acquisitions
Cancer Treatments
From
Benzinga
CSPC Pharma Pursues Licensing Deals After Lackluster Earnings
June 12, 2025
Tickers
ASIA
Tags
Opinion
contributors
Equities
From
Benzinga
Giant Biogene Bruised In A 'Battle Of The Skincare Belles'
June 12, 2025
Tickers
ASIA
Tags
Expert Ideas
Global
Benzinga
From
Benzinga
< Previous
1
2
...
26
27
28
29
30
31
32
33
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.